Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1974
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1974
Report date:
1974

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
not specified
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Reaction mass of disodium 1-amino-4-[[3-[(2,3-dibromo-1-oxopropyl)amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate and disodium 1-amino-4-[[3-[(2-bromo-1-oxoallyl)amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
Molecular formula:
C26H20.85Br1.82Na1.97N3O9S2
IUPAC Name:
Reaction mass of disodium 1-amino-4-[[3-[(2,3-dibromo-1-oxopropyl)amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate and disodium 1-amino-4-[[3-[(2-bromo-1-oxoallyl)amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
Test material form:
other: solid
Details on test material:
None

Test animals

Species:
rat
Strain:
other: Tif. RAI rats
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 6 to 7 weeks
- Weight at study initiation: 160 to 180 g
- Fasting period before study: The rats were starved during one night before starting the treatment.
- Housing: The males and females were segregated and housed in Macrolon cages (Type 3) in groups of 5 in a room.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 1
- Humidity (%): approximately 50

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
polyethylene glycol
Remarks:
PEG 400
Details on oral exposure:
FAT 40069/A was suspended at 30 % with polyethylene glycol (PEG 400).
Doses:
-3170, 3590, 4000, 4640, 6000 and 7750 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
Statistics:
The LD50 was calculated by probit analysis method (Goulden A., Methods of Statistical Analysis, John Wiley and Sons, 1960, 3rd printing, pages 404-408).

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
5 408 mg/kg bw
Based on:
test mat.
95% CL:
4 645 - 6 295
Mortality:
Yes
Clinical signs:
other: Within 2 hours after treatment the rats in all dosage groups showed sedation, dyspnoea, exophthalmos, curved position and ruffled fur. These symptoms became more accentuated as the dose was increased. The surviving animals had recovered within 8 to 11 day
Gross pathology:
Autopsy in dead and killed animals: No substance related gross organ changes were seen.
Other findings:
None

Any other information on results incl. tables

Mortality:

 Dose mg/kg  Concentration % of formulation     No of Animals                             Died within
     m  f  m 1hr f 1hr  m 24 hrs  f24 hrs  m 48 hrs  f 48 hrs  m 7 d f  7 d m 14 d  f 14 d
 3170  30  5  5  0  0  0  0  0  0  0  0  0
 3590  30  5  5  0  0  0  0  0  0  1  0  1
 4000  30  5  5  0
 4640  30  5  5  0  0  1  2  4  2  4  2  4
 6000  30  5  5  0  0  3
 7750  30  5  5  0  0  4
                  No higher dosed were possible                      

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The acute oral median lethal dose (LD50) of FAT 40069/A in rats of both sexes observed over a period of 14 days is 5408 mg/kg (95 % confidence level 4645-6295 mg/kg).
Executive summary:

An acute oral toxicity was determined for FAT 40069/A using Tif. RAI rats (30 males and 30 females). Before administration by oral intubation, FAT 40069/A was suspended at 30 % with polyethylene glycol (PEG 400). The test material was administered at different doses (5 males and 5 females rats per dose): 3170, 3590, 4000, 4640, 6000 and 7750 mg/kg. Within 2 hours after treatment the rats in all dosage groups showed sedation, dyspnea, exophthalmos, curved position and ruffled fur. These symptoms became more accentuated as the dose was increased. The surviving animals had recovered within 8 to 11 days. They were killed and autopsied after an observation period of 14 days.At autopsy no substance related gross organ changes were seen. Mortality were seen in group of rats with dose at 3590 mg/kg body weight and above. The mortality observed was 1/10, 1/10, 6/10, 7/10 and 7/10 at 3590, 4000, 4640, 6000 and 7000 mg/kg bw, respectively. In conclusion, the acute oral LD50 of FAT 40069/A in rats of both sexes observed over a period of 14 days is 5408 mg/kg (95 % confidence level 4645-6295 mg/kg). The compound has therefore a slight acute toxicity to the rat by this route of administration.